5-fluoro-2-isopropyl-3-methyl-1H-indole | 1268250-35-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-fluoro-2-isopropyl-3-methyl-1H-indole
• 英文别名: 5-fluoro-3-methyl-2-propan-2-yl-1H-indole
• CAS: 1268250-35-6
• 化学式: C₁₂H₁₄FN
• 分子量: 191.248
• InChiKey: OUUUCDPDCFVMMU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  甲基異丙基乙炔 、 2-(叔丁基)-6-氟-4H-苯并[d][1,3]恶嗪-4-酮 在 bis(1,5-cyclooctadiene)nickel (0) 、 三丙基磷 、 sodium thiomethoxide 、 水 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 、 甲醇 、 二氯甲烷 为溶剂， 25.0~160.0 ℃ 、101.33 kPa 条件下， 反应 28.0h， 以43%的产率得到5-fluoro-3-isopropyl-2-methyl-1H-indole
  参考文献：
  名称：

  Nickel-Catalyzed Cycloaddition of Anthranilic Acid Derivatives to Alkynes

  摘要：

  A nickel-catalyzed cycloaddition has been developed where readily available anthranilic acid derivatives react with alkynes to afford substituted indoles. The reaction involves oxidative addition of Ni(0) to an ester moiety, which allows intermolecular addition to alkynes via decarbonylation and 1,3-acyl migration.

  DOI：

  10.1021/ol200090g

文献信息

• (HETERO)ARYL CYCLOHEXANE DERIVATIVES
  申请人：Zemolka Saskia

  公开号：US20090247573A1

  公开（公告）日：2009-10-01

  The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

  该发明涉及对μ-阿片受体和ORL 1-受体具有亲和力的化合物，这些化合物的生产方法，含有这些化合物的药物以及这些化合物用于治疗疼痛和其他状况的使用方法。
• 2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
  申请人：Huesca Mario

  公开号：US20100168417A1

  公开（公告）日：2010-07-01

  2-indolyl imidazo[4,5-d]phenanthroline compounds of Formula I that are capable of intracellular chelation of transition metals and of exerting antiproliferative effects in cancer cells, that are cytostatic and/or cytotoxic, are provided. Compounds of Formula I can also induce apoptosis in cancer cells and are thus capable of exerting a cytotoxic effect on cancer cells. The compounds of Formula I are also capable of selectively inhibiting the proliferation of one or more of prostate cancer cells, colon cancer cells, non-small lung cancer cells and leukemia cells. The compounds of Formula I are also capable of increasing the expression of the zinc-regulated tumour suppressor, KLF4 and thus are useful in inhibiting the proliferation of cancer cells in which KLF4 functions as a tumour-suppressor, including, but not limited to, bladder cancer, cancers of the gastrointestinal tract and various leukemias.

  提供了能够在细胞内与过渡金属螯合并对癌细胞产生抗增殖作用的Formula I的2-吲哚基咪唑并[4,5-d]菲啰啉化合物，这些化合物具有细胞静止和/或细胞毒作用。Formula I的化合物还可以诱导癌细胞凋亡，因此能够对癌细胞产生细胞毒作用。Formula I的化合物还能够选择性地抑制前列腺癌细胞、结肠癌细胞、非小细胞肺癌细胞和白血病细胞中的一个或多个的增殖。Formula I的化合物还能够增加锌调节的肿瘤抑制基因KLF4的表达，因此在抑制KLF4作为肿瘤抑制基因发挥作用的癌细胞的增殖方面具有用处，包括但不限于膀胱癌、胃肠道癌和各种白血病。
• US7977370B2
  申请人：——

  公开号：US7977370B2

  公开（公告）日：2011-07-12
• US8148392B2
  申请人：——

  公开号：US8148392B2

  公开（公告）日：2012-04-03
• Nickel-Catalyzed Cycloaddition of Anthranilic Acid Derivatives to Alkynes
  作者：Nobuyoshi Maizuru、Tasuku Inami、Takuya Kurahashi、Seijiro Matsubara

  DOI：10.1021/ol200090g

  日期：2011.3.4

  A nickel-catalyzed cycloaddition has been developed where readily available anthranilic acid derivatives react with alkynes to afford substituted indoles. The reaction involves oxidative addition of Ni(0) to an ester moiety, which allows intermolecular addition to alkynes via decarbonylation and 1,3-acyl migration.